Induction of autoimmunity in Brown Norway rats by oral and parenteral administration of sodium silicate

Lupus

Volumn 18, Issue 5, 2009, Pages 413-417

  Al Mogairen, Sultan M ^a,b   Al Arfaj, A S ^a   Meo, S A ^b   Al Hammad, A ^a   Gad El Rab, M O ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Autoimmunity; Brown Norway rats; Silica; Sodium silicate

Indexed keywords

ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G; LA ANTIBODY; RO ANTIBODY; SILICATE; SILICATE SODIUM; SM ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BROWN NORWAY RAT; CONTROLLED STUDY; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; INJECTIONS, SUBCUTANEOUS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RATS; SILICATES;

EID: 63749098166     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308098192     Document Type: Article

References (14)

1. Otsuki T Maeda M Murakami S. Immunological effects of silica and asbestos. Cell Mol Immunol 2007; 4: 261-268.
2. Parks CG Cooper GS et al. Occupational exposures and risk of systemic lupus erythematosus: A review of the evidence and exposure assessment methods in population and clinic-based studies. Lupus 2006; 15: 728-736.
3. Brown JM Archer AJ Pfau JC Holian A. Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice. Clin Exp Immunol 2003; 131: 415-421.
4. Moulin P Lehucher-Michel MP. Wegener's disease and exposure to silica. Study of the physiopathological mechanisms. Presse Med 2004; 33: 1349-1351.
5. McDonald AH Weir K Schneider M Gudenkauf L Sanger JR. Silicone gel enhances the development of autoimmune disease in New Zealand black mice but fails to induce it in BALB/cAnPt mice. Clin Immunol Immunopathol 1998; 87: 248-255.
6. Simard JF Costebader KH. What can epidemiology tell us about systemic lupus erythematosus. Int J Clin Pract 2007; 61: 1170-1180.
7. Brown JM Schwanke CM Pershouse MA Pfau JC Holian A. Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice. Am J Physiol Lung Cell Mol Physiol 2005; 289: L990-L998.
8. Calvert GM Rice FL Boiano JM Sheehy JW Sanderson WT. Occupational silica exposure and risk of various diseases: An analysis using death certificates from 27 states of the United States. Occup Environ Med 2003; 60: 122-129.
9. Greenland S Finkle WD. A restrospective cohort study of implanted medical devices and selected chronic diseases in Medicare claims data. Ann Epidemiol 2000; 10: 205-213.
10. Pfau JC Brown JM Holian A. Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology 2004; 195: 167-176.
11. Cooper GS Parks CG. Occupational and environmental exposures as risk factors for systemic lupus erythematosus. Current Rheumatol Rep 2004; 6: 367-374.
12. Fournie GJ Saoudi A Druet P Pelletier L. Th2-type immunopathological manifestations induced by mercury chloride or gold salts in the rat: signal transduction pathways, cellular mechanisms and genetic control. Autoimmun Rev 2002; 1: 205-212.
13. Finckh A Cooper GS Chibnik LB et al. Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis Rheum 2006; 54: 3648-3654.
14. Miller H Zhang J Kuolee R Patel GB Chen W. Intestinal M cells: The fallible sentinels. World J Gastroenterol 2007; 13: 1477-1486.